The Business Times
business-time-50

Fresh off one deal, Allergan CEO Saunders sets his sights on more

Published Tue, Jul 28, 2015 · 09:50 PM

New York

ALLERGAN plc CEO Brent Saunders is ready to put the US$36 billion his company will net from the sale of its generics business to Teva Pharmaceutical Industries Ltd to work, possibly with another large, "transformational" merger.

The readiness for a new transaction just after the Teva deal was announced on Monday represents what Mr Saunders calls a strategy to remain nimble and open to opportunity as the healthcare sector remakes itself.

TRENDING NOW

Broadcom CEO Hock Tan (left) and Intel CEO Lip-Bu Tan (right) in a panel discussion moderated by DBS’ CEO Tan Su Shan.

Companies still in search of AI use cases with worthwhile ROI, says Broadcom’s CEO

Sultan Ibrahim Iskandar’s S$6.1 million purchase comes as the iron ore producer expands its presence in Malaysia’s rare earths industry.

Malaysian king buys stake in Singapore-listed mining firm expanding into rare earths

Malaysian Chinese bag-maker Liew Bin now sees value in protectionist measures as low-cost competition from China threatens Malaysian small and medium-sized enterprises.

Once staunchly pro-China, Malaysian Chinese businesses are now distancing themselves from Beijing

The wealthy buy time, synthesis and judgment. Everyone else is handed information and left to assemble it themselves.

Singapore’s wealth management success should extend to everyday families

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More